Table 4 Analyses of the associations between treatment aspects and survival status in 160 critically ill ILD patients.

Immunosuppressive agents

25 (43.1%)

33 (32.4%)

0.174

Conventional oxygen therapy

53 (96.4%)^b

70 (69.3%)^c

0.000

Non-invasive ventilator

12 (21.8%)^b

64 (63.4%)^c

0.000

Invasive ventilator

0 (0.0%)^b

12 (11.9%)^c

0.008

Sedative

14 (24.1%)

66 (64.7%)

0.000

High-dose glucocorticoid (>1 mg/kg/d) therapy

32 (55.2%)

74 (72.5%)

0.025

Beta lactam antibiotic

50 (86.2%)

67 (65.7%)

0.005

Carbapenem

20 (34.5%)

62 (60.8%)

0.001

Sulfonamide

32 (55.2%)

68 (66.7%)

0.149

Quinolones

20 (34.5%)

29 (28.4%)

0.425

Glycopeptide

1 (1.7%)

13 (12.7%)

0.018

Macrolides

0 (0.0%)

2 (2.0%)

0.283

Antiviral therapy

36 (62.1%)

69 (67.6%)

0.475

Antifungal therapy

21 (36.2%)

58 (56.9%)

0.012